However, comparisons between BRAF-mutant melanoma and CRC cell lines revealed that RAF inhibitors led to sustained suppression of mitogen-activated protein kinase (MAPK) signaling in melanoma cells, whereas CRCs exhibited only transient suppression of the pathway.5,6. This evidence concerns the gene BRAF and colorectal carcinoma.